How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests
For clinical labs, the proposed law could bring more consistency to test ordering
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
How the MolDX® program works, what it covers, and how it can support better test access, use, and reimbursement in the clinical lab
The current landscape of medical laboratory networks and challenges that will need to be addressed to improve data sharing and efficiency.
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Three main risks to consider when it comes to personal electronic devices, and how to safely incorporate their use in the laboratory
How might a modestly sized lab or pathology group harness technology to address their recruitment needs?